leisure time -WSS

leisure time

author：entertainment 2025-09-29 07:28:12 - browse：79

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Young boy dies in trial for Pfizer Duchenne gene therapy

entertainment

WSS

What PEPFAR has meant on the ground in Ukraine

Roche to buy Carmot Therapeutics, developer of obesity drugs

Scientific mystery highlights the blind spots in genomics databases

Covid silver lining: Unprecedented look at human immune system

AI models in health care face new federal disclosure requirements

Four alarming medical procedures we’re glad history forgot

hotspot

leisure time

entertainment

Walensky prepares to leave CDC — and Congress — behind

Radiology is caught between AI's potential and concern for patients

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Gut bacteria may contribute to kidney autoimmunity, study finds

Supreme Court strikes down use of affirmative action

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medicare Advantage 2025 payments will dip, Biden administration says

Tori Bowie and the unacceptable rates of Black maternal death

First Opinion on colorectal cancer screening: letter and response

Wikipedia

Trial using CRISPR to edit HIV out of cells disappoints

Bird flu reported in person exposed to presumably infected cattle

Study: Black kids more likely to die after surgery than white kids

Pfizer plans to depart BIO

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Pfizer plans to depart BIO

Wikipedia

hotspot

entertainment

entertainment